FDA — authorised 2 June 1994
- Application: NDA020314
- Marketing authorisation holder: CURIUM
- Local brand name: OCTREOSCAN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Indium-111 Pentreotide in United States
FDA authorised Indium-111 Pentreotide on 2 June 1994
Marketing authorisation
Frequently asked questions
Is Indium-111 Pentreotide approved in United States?
Yes. FDA authorised it on 2 June 1994.
Who is the marketing authorisation holder for Indium-111 Pentreotide in United States?
CURIUM holds the US marketing authorisation.